Shortly after streptomycin was introduced in the treatment of tuberculosis, two major obstacles to its value as a therapeutic agent became apparent. These were, vestibular damage and development of bacterial resistance. With the reduction in the daily dosage from 2 gm. and higher, to 1 gm. and later to 0.5 gm., serious vestibular damage has been eliminated. However, development of bacterial res...